Association between body composition and cardiometabolic disease risk – role of dietary fat intake and APOLIPOPROTEIN E genotype on this relationship

[thumbnail of Open Access]
Preview
Text (Open Access) - Published Version
· Available under License Creative Commons Attribution.
· Please see our End User Agreement before downloading.
| Preview
Available under license: Creative Commons Attribution
[thumbnail of PNS_FINAL251023_corrections_CLEAN COPY.pdf]
Text - Accepted Version
· Restricted to Repository staff only
Restricted to Repository staff only

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Ozen, E. orcid id iconORCID: https://orcid.org/0000-0001-6203-7018, Lovegrove, J. A. orcid id iconORCID: https://orcid.org/0000-0001-7633-9455 and Jackson, K. G. orcid id iconORCID: https://orcid.org/0000-0002-0070-3203 (2024) Association between body composition and cardiometabolic disease risk – role of dietary fat intake and APOLIPOPROTEIN E genotype on this relationship. Proceedings of the Nutrition Society. ISSN 0029-6651 doi: 10.1017/S0029665124000053

Abstract/Summary

Excess body weight is associated with increased mortality and risk of developing cardiovascular diseases (CVD). Body fat distribution is now considered a better indicator of disease risk than body mass index (BMI), with central adiposity associated with dyslipidaemia and insulin resistance. Dietary modification is unquestionably important in the prevention of obesity and CVD, with the type but not the amount of dietary fat emerging as an important determinant of both diseases. Although reducing saturated fat (SFA) intake via replacement with unsaturated fatty acids (UFA) is a key public health strategy for CVD prevention, variability in the lipid lowering response has been observed. This narrative review aims to investigate the link between adiposity and CVD risk, and the role of dietary fat composition and APOLIPOPROTEIN (APO)E genotype on this relationship. In the absence of weight loss, replacing dietary SFA with UFA reduces central adiposity and anthropometric measures, and is linked with lower total and low-density lipoprotein-cholesterol concentrations. However, differences in study populations and body composition techniques needs to be taken into consideration. To date, only a limited number of studies have determined the role of APOE on body composition and CVD risk but findings are inconsistent. Both APOE2 and APOE4 alleles have been correlated with adiposity related markers and an APOE genotype-BMI interaction has been reported on fasting lipids. However, studies are often performed retrospectively leading to small sample sizes within the genotype groups. Further studies are needed to confirm the relationship between APOE genotype, adiposity and circulating CVD risk markers

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/114627
Identification Number/DOI 10.1017/S0029665124000053
Refereed Yes
Divisions Interdisciplinary centres and themes > Institute for Cardiovascular and Metabolic Research (ICMR)
Interdisciplinary Research Centres (IDRCs) > Institute for Food, Nutrition and Health (IFNH)
Life Sciences > School of Chemistry, Food and Pharmacy > Department of Food and Nutritional Sciences > Human Nutrition Research Group
Publisher Cambridge University Press
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar